Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 178

1.
2.

Survival of HIV-1 in syringes.

Abdala N, Stephens PC, Griffith BP, Heimer R.

J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Jan 1;20(1):73-80.

PMID:
9928733
3.

Can HIV-1-contaminated syringes be disinfected? Implications for transmission among injection drug users.

Abdala N, Gleghorn AA, Carney JM, Heimer R.

J Acquir Immune Defic Syndr. 2001 Dec 15;28(5):487-94.

PMID:
11744839
4.

Strategies to optimize the impact of needle exchange programs.

Rich JD, Strong LL, Mehrotra M, Macalino G.

AIDS Read. 2000 Jul;10(7):421-9.

PMID:
10932846
5.

Clean needles save lives. HIV and injecting drug use.

James B.

AIDS Action. 1993 Jun-Aug;(21):4-5.

PMID:
12345208
6.

Strict syringe laws in Rhode Island are associated with high rates of reusing syringes and HIV risks among injection drug users.

Rich JD, Dickinson BP, Liu KL, Case P, Jesdale B, Ingegneri RM, Nolan PA.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18 Suppl 1:S140-1. No abstract available.

PMID:
9663638
7.

More free syringes, fewer drug injectors in the case of Spain.

Bravo MJ, Royuela L, Barrio G, de la Fuente L, Suarez M, Teresa Brugal M.

Soc Sci Med. 2007 Oct;65(8):1773-8. Epub 2007 Jul 19.

PMID:
17658207
8.

Survival of HIV-1 in syringes: effects of temperature during storage.

Abdala N, Reyes R, Carney JM, Heimer R.

Subst Use Misuse. 2000 Aug;35(10):1369-83.

PMID:
10921429
9.

Antibodies to the human immunodeficiency virus in needles and syringes used by intravenous drug abusers.

Wodak A, Dolan K, Imrie AA, Gold J, Wolk J, Whyte BM, Cooper DA.

Med J Aust. 1987 Sep 21;147(6):275-6.

PMID:
3650679
10.

Reducing the risk of HIV infection associated with illicit drug use.

American Academy of Pediatrics Committee on Pediatric AIDS.

Pediatrics. 2006 Feb;117(2):566-71.

PMID:
16452382
11.

HIV and harm reduction for injection drug users.

Brettle RP.

AIDS. 1991 Feb;5(2):125-36. Review. No abstract available.

PMID:
2031687
12.

Access to syringes in three Russian cities: implications for syringe distribution and coverage.

Sarang A, Rhodes T, Platt L.

Int J Drug Policy. 2008 Apr;19 Suppl 1:S25-36. doi: 10.1016/j.drugpo.2007.11.008. Epub 2008 Mar 3.

PMID:
18313910
13.

Following the blood: syringe reuse leads to blood-borne virus transmission among injection drug users.

Koester S.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18 Suppl 1:S139-40. No abstract available.

PMID:
9663637
14.

Community pharmacies and prevention of AIDS among injecting drug users.

Sloan DS.

BMJ. 1989 Dec 16;299(6714):1525-6. No abstract available.

15.

Syringe type and drug injector risk for HIV infection: a case study in Texas.

Zule WA, Desmond DP, Neff JA.

Soc Sci Med. 2002 Oct;55(7):1103-13.

PMID:
12365524
16.

[AIDS prevention in drug addicts: securing the provision of sterile syringes].

[No authors listed]

Schweiz Rundsch Med Prax. 1993 Aug 10;82(32):866. German. No abstract available.

PMID:
8372283
18.

Social context of needle selling in Baltimore, Maryland.

Latkin CA, Davey MA, Hua W.

Subst Use Misuse. 2006;41(6-7):901-13.

PMID:
16809178
19.
20.

Prescribing syringes to injection drug users: what the family physician should know.

Rich JD, Taylor L, Mehrotra M, Mason R, Stozek M, Stancliff S.

Am Fam Physician. 2003 Jul 1;68(1):45-7. No abstract available.

Supplemental Content

Support Center